Novartis (NVS) broke ground yesterday on its more than 700,000-square-foot flagship manufacturing hub in North Carolina, moving rapidly to construct its recently announced investment in the state. The North Carolina project will include the construction of a new facility in Morrisville and a new site in Durham encompassing two new facilities, as well as the expansion of an existing Novartis facility in Durham. Together, these investments are expected to create 700 new jobs in North Carolina by 2030 and support more than 3,000 indirect jobs across the Novartis US supply chain. This expansion is a key pillar in the company’s $23 billion investment in US-based infrastructure over the next five years.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- Novartis price target raised to $112 from $106 at HSBC
- Novartis announces results from Phase III VAYHIT2 trial
- Novartis announces results on breast cancer patients treated with Kisqali
- Novartis upgraded to Overweight from Neutral at JPMorgan
- Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’